BioSpace News Archive

Aphios Corporation announced today its research demonstrated that orally-administered nanoparticle-encapsulated Bryostatin-1 activates α-secretase and PKC isoforms in vitro, and facilitates acquisition and retention of spatial learning in vivo in an Alzheimer’s disease mouse model.

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Tuesday, May 11, 2021, at 8:00 a.m. ET to review its first quarter 2021 financial results and provide an update on the company.

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its first quarter 2021 financial results and provide a corporate update on Tuesday, May 11, 2021.

Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission in patients with autoimmune (‘1805 a protein drug) and allergic disease (‘1104 a peptide drug), announced today positive data from a multiple ascending dose (MAD) Phase 1 clinical trial evaluating the safety and tolerability of ‘1104, a first-in-class peptide for the treatment of allergic disease

Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, today announced that management will participate in the Oppenheimer 6th Annual Emerging Growth Conference taking place virtually May 11-12, 2021.

NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, today announced that Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes, will present a corporate overview at the Emerging Medtech Summit 2021, on May 12, 2021 at 3:57 p.m. PT in Dana Point, Ca.

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announces the Company has recently been issued U.S. Patent 10993624 “Systems And Methods For Thermoacoustic Transducer Optimization” and U.S. Patent 10996163 “Acoustically Isolated Thermoacoustic Imaging Probe and Process of Manufacture” from the United States Patent & Trademark Office.

BioSolution Designs closes initial Seed Round of funding to accelerate its ongoing product invention activities.

The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an average day, offers participants a chance to be one of 20 winners who will receive a curated self-care package

Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day.